FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307190941> ?p ?o ?g. }

• W4307190941 abstract "Durvalumab is approved for the treatment of lung cancer, advanced biliary tract cancers, and is also being evaluated in many other solid organ tumors. The aim of our study is to define the incidence, etiology, and outcomes of liver injury in consecutive patients receiving durvalumab-based immunotherapy.Durvalumab treated patients between 1/2016 - 7/2020 were identified from the electronic medical record. Liver injury was defined as serum AST or ALT ≥ 5x upper limit of normal (ULN), ALP ≥ 2x ULN, bilirubin ≥ 2.5 mg/dl, or INR ≥ 1.5. Potential drug induced liver injury (DILI) cases were adjudicated using expert opinion scoring and confirmed with Roussel Uclaf Causality Assessment Method (RUCAM).Amongst 112 patients, 58 (52%) had non-small cell lung cancer, the median age was 65 years, and 60% were male. The 21 (19%) liver injury patients were significantly more likely to harbor hepatic metastases (52% vs 17%, p=<0.001), experience tumor progression (67% vs 32%, p=0.01) or die (48% vs 11%, p<0.001) during follow-up compared to the 91 without liver injury. Using multivariate regression analysis, the development of liver injury during treatment as well as baseline hepatic metastases were independently associated with mortality during follow-up. Six of the 21 (29%) liver injury cases were adjudicated as probable DILI with four attributed to durvalumab and two due to other drugs (paclitaxel, pembrolizumab). Durvalumab was permanently discontinued in two DILI patients, three received corticosteroids, and one was successfully rechallenged. Only one patient with DILI developed jaundice, and none required hospitalization. Liver biochemistries normalized in all 6 DILI cases, while they only normalized in 27% of the 15 non-DILI cases (p=0.002). The 6 DILI patients also had a trend towards improved survival compared to those with other causes of liver injury.Liver injury was observed in 19% of durvalumab-treated patients and is associated with a greater likelihood of tumor progression and death during follow-up. The four durvalumab DILI cases were mild and self-limited, highlighting the importance of causality assessment to determine the cause of liver injury in oncology patients receiving immunotherapy." @default.
• W4307190941 created "2022-10-29" @default.
• W4307190941 creator A5009282034 @default.
• W4307190941 creator A5028299369 @default.
• W4307190941 creator A5043650720 @default.
• W4307190941 creator A5063597784 @default.
• W4307190941 creator A5064916477 @default.
• W4307190941 date "2022-10-24" @default.
• W4307190941 modified "2023-10-14" @default.
• W4307190941 title "Liver injury during durvalumab-based immunotherapy is associated with poorer patient survival: A retrospective analysis" @default.
• W4307190941 cites W2060470911 @default.
• W4307190941 cites W2123176392 @default.
• W4307190941 cites W2218985750 @default.
• W4307190941 cites W2745624257 @default.
• W4307190941 cites W2753065806 @default.
• W4307190941 cites W2802509580 @default.
• W4307190941 cites W2802561155 @default.
• W4307190941 cites W2893824814 @default.
• W4307190941 cites W2943781197 @default.
• W4307190941 cites W2952953974 @default.
• W4307190941 cites W2957570007 @default.
• W4307190941 cites W2960526624 @default.
• W4307190941 cites W2977392388 @default.
• W4307190941 cites W3011161235 @default.
• W4307190941 cites W3043457053 @default.
• W4307190941 cites W3045492728 @default.
• W4307190941 cites W3046923728 @default.
• W4307190941 cites W3087466624 @default.
• W4307190941 cites W3091493895 @default.
• W4307190941 cites W3110002524 @default.
• W4307190941 cites W3119086885 @default.
• W4307190941 cites W3137208756 @default.
• W4307190941 cites W3199228391 @default.
• W4307190941 cites W4226360696 @default.
• W4307190941 cites W4281630496 @default.
• W4307190941 cites W4286461708 @default.
• W4307190941 doi "https://doi.org/10.3389/fonc.2022.984940" @default.
• W4307190941 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36353563" @default.
• W4307190941 hasPublicationYear "2022" @default.
• W4307190941 type Work @default.
• W4307190941 citedByCount "5" @default.
• W4307190941 countsByYear W43071909412022 @default.
• W4307190941 countsByYear W43071909412023 @default.
• W4307190941 crossrefType "journal-article" @default.
• W4307190941 hasAuthorship W4307190941A5009282034 @default.
• W4307190941 hasAuthorship W4307190941A5028299369 @default.
• W4307190941 hasAuthorship W4307190941A5043650720 @default.
• W4307190941 hasAuthorship W4307190941A5063597784 @default.
• W4307190941 hasAuthorship W4307190941A5064916477 @default.
• W4307190941 hasBestOaLocation W43071909411 @default.
• W4307190941 hasConcept C121608353 @default.
• W4307190941 hasConcept C126322002 @default.
• W4307190941 hasConcept C141071460 @default.
• W4307190941 hasConcept C2776231280 @default.
• W4307190941 hasConcept C2776256026 @default.
• W4307190941 hasConcept C2776637226 @default.
• W4307190941 hasConcept C2777701055 @default.
• W4307190941 hasConcept C2777742743 @default.
• W4307190941 hasConcept C2780030458 @default.
• W4307190941 hasConcept C71924100 @default.
• W4307190941 hasConcept C90924648 @default.
• W4307190941 hasConceptScore W4307190941C121608353 @default.
• W4307190941 hasConceptScore W4307190941C126322002 @default.
• W4307190941 hasConceptScore W4307190941C141071460 @default.
• W4307190941 hasConceptScore W4307190941C2776231280 @default.
• W4307190941 hasConceptScore W4307190941C2776256026 @default.
• W4307190941 hasConceptScore W4307190941C2776637226 @default.
• W4307190941 hasConceptScore W4307190941C2777701055 @default.
• W4307190941 hasConceptScore W4307190941C2777742743 @default.
• W4307190941 hasConceptScore W4307190941C2780030458 @default.
• W4307190941 hasConceptScore W4307190941C71924100 @default.
• W4307190941 hasConceptScore W4307190941C90924648 @default.
• W4307190941 hasLocation W43071909411 @default.
• W4307190941 hasLocation W43071909412 @default.
• W4307190941 hasLocation W43071909413 @default.
• W4307190941 hasLocation W43071909414 @default.
• W4307190941 hasOpenAccess W4307190941 @default.
• W4307190941 hasPrimaryLocation W43071909411 @default.
• W4307190941 hasRelatedWork W2285109017 @default.
• W4307190941 hasRelatedWork W2802256694 @default.
• W4307190941 hasRelatedWork W2923986778 @default.
• W4307190941 hasRelatedWork W2969038597 @default.
• W4307190941 hasRelatedWork W2972926806 @default.
• W4307190941 hasRelatedWork W2995846969 @default.
• W4307190941 hasRelatedWork W3019495616 @default.
• W4307190941 hasRelatedWork W3101665383 @default.
• W4307190941 hasRelatedWork W3104083510 @default.
• W4307190941 hasRelatedWork W4292999071 @default.
• W4307190941 hasVolume "12" @default.
• W4307190941 isParatext "false" @default.
• W4307190941 isRetracted "false" @default.
• W4307190941 workType "article" @default.